CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – Venezuela

Invite Credit Card Holder to pay

Requester Details

Credit Card Holder Details

Company Details

Message to be included

GlobalData, the industry analysis specialist, has released its latest report: “CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – Venezuela”. The report is an essential source of information on analysis of the healthcare, regulatory and reimbursement landscape in Venezula. It identifies the key trends in the country’s healthcare market and provides insights into its demographic, regulatory, and reimbursement landscape and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets. It uses data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData’s team of industry experts.

Venezuela’s population grew from 28.1 million in 2009 to 31 million in 2016. The value of the pharmaceuticals market increased from $5.7 billion in 2009 to $14.4 billion in 2016 at a Compound Annual Growth Rate (CAGR) of 14.1%, and this value is expected to increase further to $27.8 billion in 2021. However, the current political and economic landscape may negatively affect the growth of the pharmaceutical market.

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in Venezuela, and includes:

  • An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
  • Profiles and SWOT analyses of the major players in the pharmaceutical market: Bayer, Abbott, Sanofi, Novartis and Merck & Co.
  • An insightful review of the reimbursement and regulatory landscape, with analysis covering details of the country’s healthcare reimbursement process, regulatory agencies and the approval processes for new drugs and medical devices
  • Detailed analysis of the country’s political and economic environment, covering economic indicators, demographics, healthcare infrastructure and healthcare expenditure
  • An overview of the opportunities for and challenges to growth in the Venezuelan healthcare market

Reasons to buy

This report will enhance your decision-making capability by allowing you to:

  • Develop business strategies by understanding the trends shaping and driving Venezuela’s healthcare market
  • Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments and companies likely to impact Venezuela’s healthcare market in the future
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing competitors’ performance
  • Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment and strategic partnership

Table of Contents

1 Table of Contents

1.1 List of Tables

1.2 List of Figures

2 Executive Summary

3 Introduction

3.1 GlobalData Report Guidance

4 ...

1 Table of Contents

1.1 List of Tables

1.2 List of Figures

2 Executive Summary

3 Introduction

3.1 GlobalData Report Guidance

4 Overview of Pharmaceutical and Medical Device Markets

4.1 Pharmaceutical Market

4.1.1 Market Overview

4.1.2 Pharmaceutical Exports and Imports

4.1.3 Supply Channels

4.1.4 Market Segments

4.1.5 Overview of Top Five Disease Areas

4.1.6 Major Players

4.2 Medical Device Market

4.2.1 Market Overview

4.3 Market Drivers and Barriers

4.3.1 Drivers

4.3.2 Barriers

5 Market Access

5.1 Overview of Healthcare system

5.2 Reimbursement and Payer Landscape

5.2.1 Overview of Insurance Providers

5.2.2 Patient Share in Healthcare Expenditure

5.2.3 Price Trends in the Healthcare Sector

5.2.4 Pricing Policies

5.3 Regulatory Landscape

5.3.1 Overview of Regulatory Agencies

5.3.2 Market Authorization Procedure for Pharmaceutical Products

5.3.3 New Medical Device Approval Process

5.3.4 Licensing Process for Pharmaceutical and Medical Device Manufacturing

5.3.5 Intellectual Property Rights

5.3.6 Clinical Trial Regulations

5.3.7 Pharmacy Regulations

5.3.8 Labeling and Packaging Regulations

6 Country Analysis

6.1 Political Environment

6.1.1 Political Structure

6.1.2 Current Political Environment

6.1.3 Healthcare Policy Initiatives

6.1.4 Economic Landscape

6.2 Economic Indicators

6.2.1 Gross Domestic Product

6.2.2 Gross National Income

6.2.3 Inflation

6.2.4 Currency Exchange Rate

6.2.5 Foreign Direct Investment

6.2.6 Foreign Exchange Reserves

6.2.7 Trade Balance

6.2.8 Government Structural Balance

6.2.9 Government Gross Debt

6.2.10 Major Industries

6.3 Demographics

6.3.1 Population

6.4 Healthcare Infrastructure

6.4.1 Healthcare Facilities

6.4.2 Healthcare Parameters

6.4.3 Environmental Health

6.5 Healthcare Expenditure

6.5.1 Overview

6.5.2 Share of Public and Private Sectors

6.5.3 Major Components of Healthcare Expenditure

6.5.4 Spending in Pharmaceutical R&D

6.6 Trade Associations

6.6.1 Venezuelan Chamber of Medicine

6.6.2 Chamber of Pharmaceutical Industry

6.6.3 Chamber of Non-prescription Medicines

6.6.4 Venezuelan Association of Distributors of Medical Equipment, Dental Laboratories and Related Products

6.6.5 Venezuelan Chamber of Pharmacy

7 Opportunities and Challenges

7.1 Opportunities

7.2 Challenges

8 Appendix

8.1 Abbreviations

8.2 Bibliography

8.3 Research Methodology

8.3.1 Coverage

8.3.2 Secondary Research

8.3.3 Forecasts

8.3.4 Expert Panel

8.4 Contact Us

8.5 Disclaimer

List of tables

Table 1: Pharmaceutical Market, Venezuela, Revenue ($bn), 2009–2016

Table 2: Pharmaceutical Market, Venezuela, Revenue ($bn), 2017–2021

Table 3: Pharmaceutical Market, Venezuela, Exports and ...

Table 1: Pharmaceutical Market, Venezuela, Revenue ($bn), 2009–2016

Table 2: Pharmaceutical Market, Venezuela, Revenue ($bn), 2017–2021

Table 3: Pharmaceutical Market, Venezuela, Exports and Imports ($bn), 2009–2016

Table 4: Pharmaceutical Market, Venezuela, Total Deaths (%), 2014

Table 5: Bayer, Global, Major Products, Revenue ($bn) and Annual Growth (%), 2016

Table 6: Pharmaceutical Market, Bayer, Global, Late-Stage Pipeline, 2017

Table 7: Sanofi, Global, Major Products, Revenue ($bn) and Annual Growth (%), 2016

Table 8: Pharmaceutical Market, Sanofi, Global, Late-stage Pipeline, 2017

Table 9: Novartis, Global, Major Products, Revenue ($bn) and Annual Growth (%), 2016

Table 10: Pharmaceutical Market, Novartis, Planned Filings, 2017–2020

Table 11: Pharmaceutical Market, Merck & Co., Global, Late-Stage Pipeline, 2017

Table 12: Healthcare Expenditure, Venezuela, Out-of-Pocket Expenditure (%), 2009–2015

Table 13: Market Access, Venezuela, Change in Average Prices of Healthcare Services (%), 2009–2015

Table 14: Market Access, Venezuela, Patent Fees ($), 2015

Table 15: Economic Indicators, Venezuela, GDP per Capita ($), 2009–2016

Table 16: Economic Indicators, Venezuela, GDP per Capita ($), 2017–2021

Table 17: Economic Indicators, Venezuela, GDP Annual Growth (%), 2009–2016

Table 18: Economic Indicators, Venezuela, GDP Annual Growth (%), 2017–2021

Table 19: Economic Indicators, Venezuela, GNI per Capita ($), 2009–2016

Table 20: Economic Indicators, Venezuela, Consumer Price Index, 2009–2016

Table 21: Economic Indicators, Venezuela, Average Consumer Price Index Annual Change (%), 2009–2016

Table 22: Economic Indicators, Venezuela, Currency Exchange Rate ($/VEF), 2009–2016

Table 23: Economic Indicators, Venezuela, Foreign Direct Investment ($bn), 2009–2015

Table 24: Economic Indicators, Venezuela, Foreign Exchange Reserves ($bn), 2009–2016

Table 25: Economic Indicators, Venezuela, Imports of Goods and Services ($bn), 2009–2016

Table 26: Economic Indicators, Venezuela, Exports of Goods and Services ($bn), 2009–2016

Table 27: Economic Indicators, Venezuela, General Government Structural Balance ($bn), 2009–2016

Table 28: Economic Indicators, Venezuela, Government Gross Debt ($bn), 2009–2016

Table 29: Economic Indicators, Venezuela, Production Index of Major Industries (physical production), 2017

Table 30: Demographics, Venezuela, Population (million), 2009–2016

Table 31: Demographics, Venezuela, Population (million), 2017–2021

Table 32: Demographics, Venezuela, Urban–Rural Population Share (%), 2009–2016

Table 33: Demographics, Venezuela, Urban–Rural Population Share (%), 2017–2021

Table 34: Demographics, Venezuela, Population Distribution by Age Group (%), 2009–2016

Table 35: Demographics, Venezuela, Population Distribution by Age Group (%), 2017–2021

Table 36: Demographics, Venezuela, Births (per 1,000 population), 2009–2016

Table 37: Demographics, Venezuela, Mortality (per 1,000 Population), 2009–2016

Table 38: Demographics, Venezuela, Major Causes of Mortality (Number of deaths), 2015

Table 39: Demographics, Venezuela, Mortality Rate of Children Under Five (per 1,000 live births), 2009–2016

Table 40: Demographics, Venezuela, Immunization Rate (%), 2009–2016

Table 41: Demographics, Venezuela, Major Causes of Male Mortality (number of deaths), 2015

Table 42: Demographics, Venezuela, Major Causes of Female Mortality (per 100,000 population), 2014

Table 43: Demographics, Venezuela, Gender Ratio (M/F), 2009–2016

Table 44: Demographics, Venezuela, Life Expectancy at Birth (years), 2009–2016

Table 45: Demographics, Venezuela, Life Expectancy at Birth (years), 2017–2021

Table 46: Demographics, Venezuela, Gross Enrollment Ratio (%), 2009–2016

Table 47: Demographics, Venezuela, Unemployment Rate (%), 2009–2016

Table 48: Demographics, Venezuela, Disability-Adjusted Life Years by Major Disease (‘000), 2015

Table 49: Healthcare Infrastructure, Venezuela, Hospitals, 2008–2013

Table 50: Healthcare Infrastructure, Venezuela, Doctors (per 1,000 population), 2009–2016

Table 51: Healthcare Infrastructure, Venezuela, PM2.5 (µg per m³), 2009–2016

Table 52: Healthcare Infrastructure, Venezuela, CO2 Emissions (metric tons per capita), 2009–2016

Table 53: Healthcare Infrastructure, Venezuela, Healthcare Expenditure as Percentage of GDP (%), 2009–2016

Table 54: Healthcare Infrastructure, Venezuela, Public–Private Share of Expenditure (%), 2009–2016

Table 55: Healthcare Infrastructure, Venezuela, Major Components of Healthcare Expenditure (%), 2014

List of figures

Figure 1: Pharmaceutical Market, Venezuela, Revenue ($bn), 2009–2021

Figure 2: Country Profile, Venezuela, 2017

Figure 3: Pharmaceutical Market, Venezuela, Revenue ($bn), 2009–2016

Figure ...

Figure 1: Pharmaceutical Market, Venezuela, Revenue ($bn), 2009–2021

Figure 2: Country Profile, Venezuela, 2017

Figure 3: Pharmaceutical Market, Venezuela, Revenue ($bn), 2009–2016

Figure 4: Pharmaceutical Market, Venezuela, Revenue ($bn), 2017–2021

Figure 5: Pharmaceutical Market, Venezuela, Exports and Imports ($bn), 2009–2016

Figure 6: Pharmaceutical Market, Venezuela, Total Deaths (%), 2014

Figure 7: Healthcare Market, Venezuela, Drivers and Barriers, 2017

Figure 8: Market Access, Venezuela, Health System, 2017

Figure 9: Healthcare Expenditure, Venezuela, Out-of-Pocket Expenditure (%), 2009–2015

Figure 10: Market Access, Venezuela, Change in Average Prices of Healthcare Services (%), 2009–2015

Figure 11: Market Access, Venezuela, Drug Approval Process, 2016

Figure 12: Market Access, Venezuela, Patent Process, 2016

Figure 13: Market Access, Venezuela, Trademark Process, 2016

Figure 14: Market Access, Venezuela, Clinical Trial Approval Process, 2016

Figure 15: Economic Indicators, Venezuela, GDP per Capita ($), 2009–2016

Figure 16: Economic Indicators, Venezuela, GDP per Capita ($), 2017–2021

Figure 17: Economic Indicators, Venezuela, GDP Annual Growth (%), 2009–2016

Figure 18: Economic Indicators, Venezuela, GDP Annual Growth (%), 2017–2021

Figure 19: Economic Indicators, Venezuela, GNI per Capita ($), 2009–2016

Figure 20: Economic Indicators, Venezuela, Consumer Price Index, 2009–2016

Figure 21: Economic Indicators, Venezuela, Average Consumer Price Index, Annual Change (%), 2009–2016

Figure 22: Economic Indicators, Venezuela, Currency Exchange Rate ($/VEF), 2009–2016

Figure 23: Economic Indicators, Venezuela, Foreign Direct Investment ($bn), 2009–2015

Figure 24: Economic Indicators, Venezuela, Foreign Exchange Reserves ($bn), 2009–2016

Figure 25: Economic Indicators, Venezuela, Imports of Goods and Services ($bn), 2009–2016

Figure 26: Economic Indicators, Venezuela, Exports of Goods and Services ($bn), 2009–2016

Figure 27: Economic Indicators, Venezuela, Government Structural Balance ($bn), 2009–2016

Figure 28: Economic Indicators, Venezuela, Government Gross Debt ($bn), 2009–2016

Figure 29: Economic Indicators, Venezuela, Production Index of Major Industries (physical production), 2017

Figure 30: Demographics, Venezuela, Population (million), 2009–2016

Figure 31: Demographics, Venezuela, Population (million), 2017–2021

Figure 32: Demographics, Venezuela, Urban–Rural Population Share (%), 2009–2016

Figure 33: Demographics, Venezuela, Urban–Rural Population Share (%), 2017–2021

Figure 34: Demographics, Venezuela, Population Distribution by Age Group (%), 2009–2016

Figure 35: Demographics, Venezuela, Population Distribution by Age Group (%), 2017–2021

Figure 36: Demographics, Venezuela, Births (per 1,000 population), 2009–2016

Figure 37: Demographics, Venezuela, Mortality (per 1,000 Population), 2009–2016

Figure 38: Demographics, Venezuela, Major Causes of Mortality (number of deaths), 2015

Figure 39: Demographics, Venezuela, Mortality Rate of Children Under Five (per 1,000 live births), 2009–2016

Figure 40: Demographics, Venezuela, Immunization Rate (%), 2009–2016

Figure 41: Demographics, Venezuela, Major Causes of Male Mortality (number of deaths), 2015

Figure 42: Demographics, Venezuela, Major Causes of Female Mortality (per 100,000 population), 2014

Figure 43: Demographics, Venezuela, Gender Ratio (M/F), 2009–2016

Figure 44: Demographics, Venezuela, Life Expectancy at Birth (years), 2009–2016

Figure 45: Demographics, Venezuela, Life Expectancy at Birth (years), 2017–2021

Figure 46: Demographics, Venezuela, Gross Enrollment Ratio (%), 2009–2016

Figure 47: Demographics, Venezuela, Unemployment Rate (%), 2009–2016

Figure 48: Demographics, Venezuela, Major Diseases, Disability-Adjusted Life Years by Major Disease (‘000s), 2015

Figure 49: Healthcare Infrastructure, Venezuela, Hospitals, 2008–2013

Figure 50: Healthcare Infrastructure, Venezuela, Doctors (per 1,000 population), 2009–2016

Figure 51: Healthcare Infrastructure, Venezuela, PM2.5 (µg per m³), 2009–2016

Figure 52: Healthcare Infrastructure, Venezuela, CO2 Emissions (metric tons per capita), 2009–2016

Figure 53: Healthcare Infrastructure, Venezuela, Healthcare Expenditure as Percentage of GDP (%), 2009–2016

Figure 54: Healthcare Infrastructure, Venezuela, Public–Private Share of Expenditure (%), 2009–2016

Figure 55: Healthcare Infrastructure, Venezuela, Major Components of Healthcare Expenditure (%), 2014

Figure 56: Healthcare Market, Venezuela, Opportunities and Challenges, 2017

    Pricing

Discounts available for multiple report purchases.

reportstore@globaldata.com
+44 (0) 161 359 5813

Saved reports

GlobalData has been a great partner for us in accessing not just market revenue data, but also clinical trial information that has been a huge resource for PathoVax

  Pathovax